{"id":5387,"date":"2008-04-02T10:07:58","date_gmt":"2008-04-02T09:07:58","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=5387"},"modified":"2013-08-30T10:03:57","modified_gmt":"2013-08-30T10:03:57","slug":"15th-conference-on-retroviruses-and-opportunistic-infections-2-6-february-2008-boston","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/5387","title":{"rendered":"15th Conference on Retroviruses and Opportunistic Infections, 2-6 February 2008, Boston"},"content":{"rendered":"<p><a href=\".\/keyword\/croi-2008\">Reports from the conference<\/a><\/p>\n<p><strong>This annual conference is one of the most important annual scientific meetings.<\/strong><\/p>\n<p>Abstracts for the meeting are online as soon as the conference opens, and many of the most important oral abstract sessions and overview sessions are posted as webcasts within a day or so. We encourage readers to go directly to the source for many of these sessions<\/p>\n<p><a href=\"http:\/\/www.retroconference.org\"><span>http:\/\/www.retroconference.org<\/span><\/a><\/p>\n<p>This issue includes reports on antiretrovirals and treatment strategies, prevention of mother to child transmission (PMTCT), hepatitis coinfection and oncology:<\/p>\n<ul>\n<li><a title=\"Permanent link to Atazanavir\/r vs lopinavir\/r in treatment-naive patients: 48 week results\" href=\"https:\/\/i-base.info\/htb\/1871\" rel=\"bookmark\">Atazanavir\/r vs lopinavir\/r in treatment-naive patients: 48 week results<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Baseline inflammation and coagulation markers and changes over four weeks during a treatment interruption are strongly linked to HIV viraemia and risk of mortality\" href=\"https:\/\/i-base.info\/htb\/1869\" rel=\"bookmark\">Baseline inflammation and coagulation markers and changes over four weeks during a treatment interruption are strongly linked to HIV viraemia and risk of mortality<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Restarting treatment after an interruption reduces the risk of serious events but CD4 recovery falls short of baseline levels\" href=\"https:\/\/i-base.info\/htb\/1867\" rel=\"bookmark\">Restarting treatment after an interruption reduces the risk of serious events but CD4 recovery falls short of baseline levels<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Very low rate of MTCT in women on HAART in UK and Ireland who achieve viral suppression\" href=\"https:\/\/i-base.info\/htb\/1865\" rel=\"bookmark\">Very low rate of MTCT in women on HAART in UK and Ireland who achieve viral suppression<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Predictors of mother to child transmission among women initiating HAART in pregnancy in a South African cohort\" href=\"https:\/\/i-base.info\/htb\/1863\" rel=\"bookmark\">Predictors of mother to child transmission among women initiating HAART in pregnancy in a South African cohort<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Maternal and infant outcomes from the DREAM programme\" href=\"https:\/\/i-base.info\/htb\/1861\" rel=\"bookmark\">Maternal and infant outcomes from the DREAM programme<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Nevirapine-resistant HIV present in the latent reservoir following single-dose nevirapine for MTCT prevention\" href=\"https:\/\/i-base.info\/htb\/1856\" rel=\"bookmark\">Nevirapine-resistant HIV present in the latent reservoir following single-dose nevirapine for MTCT prevention<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Tenofovir plus FTC reduce NNRTI resistance following single dose nevirapine\" href=\"https:\/\/i-base.info\/htb\/1854\" rel=\"bookmark\">Tenofovir plus FTC reduce NNRTI resistance following single dose nevirapine<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Response to treatment after single dose NVP exposure in women\" href=\"https:\/\/i-base.info\/htb\/1850\" rel=\"bookmark\">Response to treatment after single dose NVP exposure in women<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Response to treatment after single dose NVP exposure in infants\" href=\"https:\/\/i-base.info\/htb\/1848\" rel=\"bookmark\">Response to treatment after single dose NVP exposure in infants<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Other studies looking at birth outcomes\" href=\"https:\/\/i-base.info\/htb\/1846\" rel=\"bookmark\">Other studies looking at birth outcomes<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Infant prophylaxis for postnatal transmission\" href=\"https:\/\/i-base.info\/htb\/1842\" rel=\"bookmark\">Infant prophylaxis for postnatal transmission<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Antiretroviral drug concentrations in breast milk and breastfeeding infants\" href=\"https:\/\/i-base.info\/htb\/1838\" rel=\"bookmark\">Antiretroviral drug concentrations in breast milk and breastfeeding infants<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Maternal breastfeeding prophylaxis\" href=\"https:\/\/i-base.info\/htb\/1833\" rel=\"bookmark\">Maternal breastfeeding prophylaxis<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Risk factors for breastfeeding transmission\" href=\"https:\/\/i-base.info\/htb\/1831\" rel=\"bookmark\">Risk factors for breastfeeding transmission<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to UK cohort reports sexual HCV reinfection in at least 5% HIV-positive gay men following sustained response to treatment\" href=\"https:\/\/i-base.info\/htb\/1829\" rel=\"bookmark\">UK cohort reports sexual HCV reinfection in at least 5% HIV-positive gay men following sustained response to treatment<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to MELD score predictive of pre-transplant mortality in HCV coinfected patients\" href=\"https:\/\/i-base.info\/htb\/871\" rel=\"bookmark\">MELD score predictive of pre-transplant mortality in HCV coinfected patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Does abacavir decrease SVR rates with HCV treatment?\" href=\"https:\/\/i-base.info\/htb\/1823\" rel=\"bookmark\">Does abacavir decrease SVR rates with HCV treatment?<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to No effect of interferon maintenance therapy on fibrosis progression in non-responders\" href=\"https:\/\/i-base.info\/htb\/1821\" rel=\"bookmark\">No effect of interferon maintenance therapy on fibrosis progression in non-responders<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Stem cell transplant from HLA-matched CCR5-delta 32 deleted donor suppresses viraemia in recipient for 8 months without HAART\" href=\"https:\/\/i-base.info\/htb\/1819\" rel=\"bookmark\">Stem cell transplant from HLA-matched CCR5-delta 32 deleted donor suppresses viraemia in recipient for 8 months without HAART<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Risk factors for AIDS-defining and non AIDS-defining cancers\" href=\"https:\/\/i-base.info\/htb\/1817\" rel=\"bookmark\">Risk factors for AIDS-defining and non AIDS-defining cancers<\/a><\/li>\n<\/ul>\n<p>Further coverage will be included in subsequent issues of HTB.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reports from the conference This annual conference is one of the most important annual scientific meetings. Abstracts for the meeting are online as soon as the conference opens, and many of the most important oral abstract sessions and overview sessions &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,62],"class_list":["post-5387","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-croi-2008"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/5387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=5387"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/5387\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=5387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=5387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=5387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}